Vanguard Personalized Indexing Management
VYGR icon

Vanguard Personalized Indexing Management’s Voyager Therapeutics VYGR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8K Sell
16,501
-1,767
-10% -$6.7K ﹤0.01% 2122
2026
Q1 		$70.5K Buy
+18,268
New +$71.9K ﹤0.01% 2007

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Personalized Indexing Management's VYGR Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Voyager Therapeutics (VYGR) stake by 9.7% in Q2 2026, selling an estimated $6.7K and leaving 16,501 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

Vanguard Personalized Indexing Management first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. The position peaked at $70.5K in Q1 2026. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Vanguard Personalized Indexing Management held 16,501 shares of Voyager Therapeutics worth $57.8K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,767 Voyager Therapeutics shares in Q2 2026, an estimated $6.7K.
  • Voyager Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2122 holding.
  • Vanguard Personalized Indexing Management first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Voyager Therapeutics position peaked at $70.5K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.